Rocky Mountain Laboratories

Rocky Mountain Laboratories (RML) is part of the NIH Intramural Research Program and is located in Hamilton, Montana. Operated by the National Institute of Allergy and Infectious Diseases, RML conducts research on maximum containment pathogens such as Ebola as well as research on prions and intracellular pathogens such as Coxiella burnetti and Francisella tularensis.[2][3][4] RML operates one of the few Biosafety level 4 laboratories in the United States, as well as Biosafety level 3 and ABSL3/4 laboratories.[5]

Rocky Mountain Laboratories

Agency overview
Formed	1928[1]
Preceding agency	Hygienic Laboratory
Headquarters	Hamilton, Montana
Employees	400[1]
Parent agency	National Institute of Allergy and Infectious Disease, National Institutes of Health, United States Department of Health & Human Services
Website

In February 2020, electron microscope images of SARS-CoV-2 were collected at RML.[6]

References

1. "Rocky Mountain Laboratories Overview, NIAID, NIH". niaid.nih.gov. Retrieved 2016-10-28.
2. "Heinz Feldmann, M.D., Ph.D., Laboratory of Virology". niaid.nih.gov. Retrieved 2016-10-28.
3. "Laboratory of Bacteriology". niaid.nih.gov. Retrieved 2016-10-28.
4. "Bruce W. Chesebro, M.D., Laboratory of Persistent Viral Diseases, NIAID, NIH". niaid.nih.gov. Retrieved 2016-10-28.
5. "Rocky Mountain Laboratories". niaid.nih.gov. Retrieved 2016-10-28.
6. Missoulian. "Hamilton lab releases new images of coronavirus". missoulian.com. Retrieved 2020-02-15.